Crystagen Research Guide

Full name: Crystagen (Immune Peptide Bioregulator)

A short synthetic peptide bioregulator from the Khavinson family targeted at immune (thymus/lymphoid) tissue. It is used in the bioregulator community to support immune regulation and resilience, typically in short repeated courses.

How Crystagen Works

As a signal peptide, it is proposed to enter cells and regulate gene expression in immune tissue, supporting normal thymic and lymphoid function, immune cell maturation, and balanced immune responses.

Dosing Protocol

• Typical dose: ~1-2 capsules/day or short injectable courses
• Frequency: Once daily
• Duration: 10-30 day courses
• Route: Oral capsule or subcutaneous

Reported Benefits

• Immune regulation support
• Thymic/lymphoid tissue support (proposed)
• Immune resilience
• Short course-based protocol
• Part of bioregulator longevity systems

Potential Side Effects

• Limited Western clinical data
• Injection site reactions (injectable)
• Unknown long-term effects

Research Citations

1. Immune peptide bioregulators (2017) - Reported to support thymic and lymphoid tissue function in regional research studies.

Related Immune Support Compounds

• Thymosin Alpha-1 - Full Profile
• Thymulin - Full Profile
• Lactoferrin - Full Profile
• Beta-Defensin - Full Profile
• TA1 - Full Profile
• Thymalin - Full Profile

View full Crystagen profile with 3D molecule viewer →